Definitive Contract 75N91024C00096
Award Date
9/16/24
Potential Completion Date
9/15/26
Potential Value
$2M
Federal Agency
National Cancer Institute
Awardee
Tibaray, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94539, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This $399,617 Firm Fixed Price contract was awarded by the National Cancer Institute (NCI) to Tibaray, Inc., a Bay Area startup that develops particle accelerator systems for cancer treatment. The contract, which is set aside for small businesses, is part of the NCI's Small Business Innovation Research (SBIR) program and funds research and development of ultra-fast dose rate (FLASH) radiation detectors and safety systems. Tibaray, a manufacturer of medical equipment, has previously received...
Tibaray, Inc. was awarded a firm fixed price contract valued at $2,407,514.14 by the Department of Energy's National Nuclear Security Administration to deliver novel low-cost medical accelerator designs for use in challenging environments. The contract supports the agency's goal of developing accelerator technologies with applications in global health by providing prototypes and research through December 2023. As the prime contractor, Tibaray will leverage its expertise in compact particle...
This is a $396,190 firm fixed price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (part of the National Institutes of Health) to Tetraimaging LLC, a small disadvantaged business, to develop ultra-fast dose rate (FLASH) radiation detectors and safety systems. The contract was awarded on September 16, 2022 and is set to complete by December 15, 2023. The original solicitation, PHS-2022-1, announced by the NIH and CDC, sought small business...
This is a $299,896 firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Radiabeam Technologies, LLC, a small business manufacturer, for the development of laser-driven proton and carbon therapy systems. The contract has no set-aside designation. Radiabeam Technologies is a leading provider of advanced accelerator technologies, specializing in the design, manufacturing, and validation of particle accelerator components and systems. Through...
This is a $398,714 firm fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Irai Technologies, LLC, a minority-owned small business. The contract is for the development of a flash dosimetry system based on ionizing radiation acoustic imaging, under Solicitation PHS-2023-1 for the NIH and CDC SBIR program. The goal is to contribute toward NCI mission needs and SBIR program objectives by stimulating technological innovation and fostering participation from small,...
This is a Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Tetraimaging LLC, a self-certified small disadvantaged business. The contract, valued at $1,999,930.00, is for the development of a multilayer strip ion chamber device to measure flash-RT beams under the SBIR (Small Business Innovation Research) Program Phase II. The period of performance is from September 16, 2024, to September 15, 2026, and the contract has a total small...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, a civilian agency, to Tetraimaging, a for-profit manufacturer, for the development of a key component of the Tetrahedron Beam Computed Tomography (TBCT) system. The TBCT system is an innovative x-ray imaging technology with improved mobility, speed, image quality, and reduced cost, which can be used for both image-guided interventions and mobile diagnostic CT scanning. The purpose of...
This is a $1,980,915.00 firm-fixed-price SBIR Phase II contract awarded by the National Cancer Institute (part of the Department of Health and Human Services) to Pyramid Technical Consultants, Inc., a for-profit manufacturing company, for the development of ultra-fast dose rate (FLASH) radiation detectors and safety systems. The contract has a period of performance from September 16, 2024 to September 15, 2026 and is set aside for a small business. The contract was awarded under SBIR Topic 434...
This is a $144,220 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Magarray, Inc. for the development of early diagnostic tools using nanotechnology-based imaging and sensing. The contract was awarded on September 28, 2007 and has a completion date of March 27, 2008. Magarray, Inc. is a for-profit manufacturer located in Mountain View, California. The contract is a firm fixed-price definitive contract, which...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Woodtoga Holdings Company, a for-profit manufacturer, for the development of "Applicator-Compatible Electronic Brachytherapy Sources for Cancer Radiotherapy." The $399,779.00 firm fixed price contract runs through December 31, 2022 and is set aside for small businesses. This contract supports the SBIR program...